Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 7/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6194134 | 0.96 | MEN1 (0.40) | MMP13MEN1ALDH1A1GAAKMT2A | |
| SCHEMBL6194013 | 0.87 | MMP13 (0.42) | MMP13MEN1ALDH1A1GAAKMT2A | |
| SCHEMBL6843282 | 0.87 | MMP13 (0.39) | MMP13MEN1ALDH1A1GAAKMT2A | |
| SCHEMBL6843025 | 0.84 | MEN1 (0.40) | MMP13MEN1ALDH1A1GAAKMT2A | |
| SCHEMBL6197213 | 0.83 | MMP13 (0.40) | MMP13MEN1ALDH1A1GAAKMT2A | |
| SCHEMBL6843302 | 0.83 | — | — | |
| SCHEMBL6217642 | 0.83 | MEN1 (0.38) | MMP13MEN1ALDH1A1GAAKMT2A | |
| SCHEMBL6210537 | 0.82 | MEN1 (0.42) | MMP13MEN1ALDH1A1GAAKMT2A | |
| SCHEMBL6213525 | 0.80 | MMP13 (0.42) | MMP13 | |
| SCHEMBL6843105 | 0.80 | MMP13 (0.40) | MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040043983-A1 | Naphthalene derivatives as matrix metalloproteinase inhibitors | LI JIE JACK (US) | 2004-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040043983-A1 | Naphthalene derivatives as matrix metalloproteinase inhibitors | MMP9, MMP8, MMP13 | MMP13 3/4885MEN1 2172/4885ALDH1A1 1588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.